|
시장보고서
상품코드
1941479
미국의 조절식 압박 붕대 시장 규모, 점유율 및 동향 분석 보고서 : 적응증 및 병태별, 최종 용도별, 유통 채널별, 지역별, 부문 예측(2026-2033년)U.S. Adjustable Compression Wraps Market Size, Share & Trends Analysis Report By Indication & Pathology (Venous Leg Ulcers, Lymphedema, Chronic Venous Insufficiency), By End Use, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
미국의 조절식 압박 붕대 시장 개요
미국의 조절식 압박 붕대 시장 규모는 2025년 1억 1,502만 달러로 추정되며, 2033년에 2억 1,490만 달러에 이를 것으로 예측됩니다.
또한 2026-2033년 연평균 7.95%의 성장률을 보일 것으로 예측됩니다. 이러한 성장은 만성 정맥 질환 및 림프부종 유병률 증가, 고령화, 수술 후 관리 및 상처 관리에서 압박 요법의 사용 증가에 의해 주도되고 있습니다.
재택치료로의 전환, 사용하기 쉽고 조절 가능한 압박 솔루션에 대한 선호도 증가, 스포츠 부문 임신 관련 부종 및 예방 의료에 대한 사용 확대 등이 시장의 성장을 뒷받침하고 있습니다.
정맥성 하지 궤양(VLU)은 압박 요법이 치료 및 장기 관리의 핵심 요소이기 때문에 미국 시장 성장을 주도하고 있습니다. VLU는 만성정맥부전의 흔한 합병증으로, 특히 고령층과 비만, 당뇨병, 운동기능저하가 있는 사람들에게서 많이 나타나며 환자 수가 크게 증가하고 있습니다. 기존 붕대에 비해 조절식 압박붕대는 일관되고 제어된 압박을 제공하고, 착용이 용이하며, 장기 치료 기간 동안 환자의 순응도를 향상시키는 데 기여하기 때문에 선호되고 있습니다.
임신 관련 순환기 질환(다리 부종, 부종, 정맥류, 정맥부전 위험 증가, 기타)의 높은 유병률로 인해 임신 관련 시장이 주도하고 있습니다. 임신 중 호르몬 변화, 체중 증가, 하반신에 가해지는 부하 증가로 인해 의료진은 혈류 개선과 불편감 감소를 위해 압박 요법을 권장합니다. 조정형 압박붕대는 임신의 각 단계에 따른 신체 변화에 대응할 수 있는 유연한 크기 조절과 압력 조절 기능을 갖추고 있어 임산부에게 특히 적합합니다. 산모 건강, 예방의학, 비침습적 치료 옵션에 대한 인식이 높아지고 산부인과 의사와 조산사의 권고로 임신 중 및 산후 압박붕대 사용이 증가하고 있으며, 이는 시장 성장에 기여하고 있습니다.
스포츠 및 레크리에이션 활동으로 인한 부상으로 인해 운동선수 및 신체활동이 많은 사람들의 지지력과 회복에 중점을 둔 압박 솔루션에 대한 수요가 증가하면서 시장을 주도하고 있습니다. 근육의 살이 찢어지거나 인대 염좌, 관절 손상, 연부조직의 부종은 스포츠 및 피트니스 활동에서 흔히 볼 수 있는 증상입니다. 조정형 압박 붕대는 부종 감소, 혈류 촉진, 회복 가속화를 목적으로 널리 사용되고 있습니다. 착용의 용이성, 재사용성, 맞춤형 압박 기능으로 훈련 중, 부상 후 재활 및 예방적 지원에 특히 적합합니다. 또한, 피트니스, 아웃도어 스포츠, 레크리에이션 활동 참여 증가, 부상 예방 및 회복 관리에 대한 인식이 높아짐에 따라 조정형 압박붕대 채택은 임상 현장을 넘어 스포츠 의료 클리닉, 체육관, 소매 채널로 확대되어 시장 성장에 크게 기여하고 있습니다. 미국 안전위원회에 따르면, 2020년 사상 최저치를 기록한 스포츠 레크리에이션 부상 건수는 2021년 20%, 2022년 12%, 2023년 2%, 2024년 17% 증가할 것으로 전망하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 미국의 조절식 압박 붕대 시장 변수, 동향과 범위
제4장 미국의 조절식 압박 붕대 시장 : 적응증·병태, 추정 및 동향 분석
제5장 미국의 조절식 압박 붕대 시장 : 최종 용도별, 추정 및 동향 분석
제6장 미국의 조절식 압박 붕대 시장 : 유통 채널별, 추정 및 동향 분석
제7장 경쟁 구도
LSH 26.03.11U.S. Adjustable Compression Wraps Market Summary
The U.S. adjustable compression wraps market size was estimated at USD 115.02 million in 2025 and is projected to reach USD 214.90 million by 2033, growing at a CAGR of 7.95% from 2026 to 2033. This growth is driven by the rising prevalence of chronic venous disorders and lymphedema, an aging population, and increasing adoption of compression therapy for post-surgical care and wound management.
The shift toward home healthcare, growing preference for easy-to-use and adjustable compression solutions, and expanding use in sports, pregnancy-related edema, and preventive care further support market expansion.
Venous leg ulcers drive the U.S. market, as compression therapy is a key component of VLU treatment and long-term management. VLU is a common complication of chronic venous insufficiency, particularly among the aging population and individuals with obesity, diabetes, or reduced mobility, leading to a large and growing patient pool. Adjustable compression wraps are preferred over traditional bandages as they provide consistent, controlled compression, are easier to apply, and support better patient adherence during prolonged treatment periods.
Pregnancy drives the market due to the high prevalence of pregnancy-related circulatory issues such as leg swelling, edema, varicose veins, and increased risk of venous insufficiency. Hormonal changes, weight gain, and increased pressure on the lower extremities during pregnancy lead healthcare providers to recommend compression therapy to improve blood circulation and reduce discomfort. Adjustable compression wraps are particularly suitable for pregnant women, as they offer flexible sizing and adjustable pressure to accommodate the body's changes throughout different stages of pregnancy. The growing awareness of maternal health, preventive care, and non-invasive management options, along with recommendations from obstetricians and midwives, is increasing the adoption of compression wraps during and after pregnancy, thereby contributing to market growth.
Sports and recreational injuries drive the market by increasing demand for supportive and recovery-focused compression solutions among athletes and physically active individuals. Muscle strains, ligament sprains, joint injuries, and soft-tissue swelling are common in sports and fitness activities. Adjustable compression wraps are widely used to reduce edema, enhance blood circulation, and promote faster recovery. Their ease of application, reusability, and ability to provide customizable compression make them particularly attractive for use during training, post-injury rehabilitation, and preventive support. In addition, growing participation in fitness, outdoor sports, and recreational activities, along with rising awareness of injury prevention and recovery management, is expanding the adoption of adjustable compression wraps beyond clinical settings into sports medicine clinics, gyms, and retail channels, thereby contributing significantly to market growth. According to the National Safety Council, following a record low number of sports and recreational injuries reported in 2020, injuries increased by 20% in 2021, 12% in 2022, 2% in 2023, and 17% in 2024.
U.S. Adjustable Compression Wraps Market Report Segmentation
This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. adjustable compression wraps market report based on indication & pathology, end use, and distribution channel:
- Indication & Pathology Outlook (Revenue, USD Million, 2021 - 2033)
- Venous Leg Ulcers (VLU)
- Lymphedema
- Deep Vein Thrombosis (DVT) / Post-thrombotic syndrome
- Chronic Venous Insufficiency
- Class 1
- Class 2
- Class 3
- Class 4
- Class 5
- Class 6
- Post-operative Edema
- Pregnancy-related Edema
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Home healthcare
- Physician's Office
- Nursing Homes
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Institutional Sales
- Retail Sales
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Indication & Pathology
- 1.1.2. End-use
- 1.1.3. Distribution Channel
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity price analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Indication & pathology outlook
- 2.2.2. Distribution Channel outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Adjustable Compression Wraps Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of venous & lymphatic disorders
- 3.2.1.2. Preventive & sports applications
- 3.2.1.3. Ease of use and self-management
- 3.2.1.4. Growing geriatric population
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of advanced products
- 3.2.3. Market Challenge Analysis
- 3.2.3.1. Patient education & awareness
- 3.2.3.2. Consumer fit & sizing issues in e-commerce channels
- 3.2.4. Market Opportunity Analysis
- 3.2.4.1. Growth in home healthcare & remote care
- 3.2.4.2. Product innovation & smart features
- 3.2.4.3. E-commerce & direct-to-consumer channels
- 3.2.1. Market Driver Analysis
- 3.3. U.S. Adjustable Compression Wraps Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's Five Forces
Chapter 4. U.S. Adjustable Compression Wraps Market: Indication & Pathology Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Adjustable Compression Wraps Market: Indication & Pathology Movement Analysis
- 4.3. U.S. Adjustable Compression Wraps Market Size & Forecasts and Trend Analysis, by Indication & Pathology, 2021 to 2033 (USD Million)
- 4.3.1. Venous Leg Ulcers (VLU)
- 4.3.1.1. Venous Leg Ulcers (VLU) market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.2. Lymphedema
- 4.3.2.1. Lymphedema market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.3. Deep Vein Thrombosis (DVT) / Post-thrombotic syndrome
- 4.3.3.1. Deep Vein Thrombosis (DVT) / post-thrombotic syndrome market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4. Chronic Venous Insufficiency
- 4.3.4.1. Chronic venous insufficiency market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4.2. Class 1
- 4.3.4.2.1. Class 1 market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4.3. Class 2
- 4.3.4.3.1. Class 2 market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4.4. Class 3
- 4.3.4.4.1. Class 3 market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4.5. Class 4
- 4.3.4.5.1. Class 4 market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4.6. Class 5
- 4.3.4.6.1. Class 5 market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.4.7. Class 6
- 4.3.4.7.1. Class 6 market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.5. Post-operative Edema
- 4.3.5.1. Post-operative edema market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.6. Pregnancy-related Edema
- 4.3.6.1. Pregnancy-related edema market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.3.1. Venous Leg Ulcers (VLU)
Chapter 5. U.S. Adjustable Compression Wraps Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Adjustable Compression Wraps Market: End Use Movement Analysis
- 5.3. U.S. Adjustable Compression Wraps Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 5.3.1. Hospitals
- 5.3.1.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.2. Specialty Clinics
- 5.3.2.1. Specialty clinics market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.3. Home healthcare
- 5.3.3.1. Home healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.4. Physician's Office
- 5.3.4.1. Physician's office market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.5. Nursing Homes
- 5.3.5.1. Nursing homes market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.6. Others
- 5.3.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.3.1. Hospitals
Chapter 6. U.S. Adjustable Compression Wraps Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Adjustable Compression Wraps Market: Distribution Channel Movement Analysis
- 6.3. U.S. Adjustable Compression Wraps Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 6.3.1. Institutional Sales
- 6.3.1.1. Institutional sales market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.2. Retail Sales
- 6.3.2.1. Retail sales market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.3.1. Institutional Sales
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. Innovators
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key company market share analysis, 2025
- 7.3.3. SIGVARIS
- 7.3.3.1. Company overview
- 7.3.3.2. Financial performance
- 7.3.3.3. Product benchmarking
- 7.3.3.4. Strategic initiatives
- 7.3.4. L&R Group
- 7.3.4.1. Company overview
- 7.3.4.2. Financial performance
- 7.3.4.3. Product benchmarking
- 7.3.4.4. Strategic initiatives
- 7.3.5. Julius Zorn GmbH
- 7.3.5.1. Company overview
- 7.3.5.2. Financial performance
- 7.3.5.3. Product benchmarking
- 7.3.5.4. Strategic initiatives
- 7.3.6. Solventum
- 7.3.6.1. Company overview
- 7.3.6.2. Financial performance
- 7.3.6.3. Product benchmarking
- 7.3.6.4. Strategic initiatives
- 7.3.7. Essity Aktiebolag
- 7.3.7.1. Company overview
- 7.3.7.2. Financial performance
- 7.3.7.3. Product benchmarking
- 7.3.7.4. Strategic initiatives
- 7.3.8. medi USA
- 7.3.8.1. Company overview
- 7.3.8.2. Financial performance
- 7.3.8.3. Product benchmarking
- 7.3.8.4. Strategic initiatives
- 7.3.9. Sun Scientific
- 7.3.9.1. Company overview
- 7.3.9.2. Financial performance
- 7.3.9.3. Product benchmarking
- 7.3.9.4. Strategic initiatives
- 7.3.10. Cardinal Health
- 7.3.10.1. Company overview
- 7.3.10.2. Financial performance
- 7.3.10.3. Product benchmarking
- 7.3.10.4. Strategic initiatives
